Inhaltsübersicht

Literature

1. Holtkotte, D., Pfeiffer, T., Pisch, T., and Bosch, V. (2006). Selection and characterization of a replication-competent human immunodeficiency virus type 1 variant encoding C-terminally truncated Env. AIDS Res. and Hum. Retroviruses, 22, 57-65.

2. Holtkotte, D., Pfeiffer, T., and Bosch, V. (2006). Generation of H9 T-cells stably expressing a membrane-bound form of the cytoplasmic tail of the Env-glycoprotein: lack of transcomplementation of defective HIV-1 virions encoding C-terminally truncated Env. Retrovirology, 3, 27.

3. Pfeiffer, T., Pisch, T., Devitt, G., Holtkotte, D., Bosch, V. (2006). Effects of signal peptide exchange on HIV-1 glycoprotein expression and viral infectivity in mammalian cells. FEBS Letters, 580, 3775-3778.

4. Krueger, A., Fas, S. C., Giaisi, M., Bleumink, M., Merling, A., Stumpf, C., Baumann, S., Holtkotte, D., Bosch, V., Krammer, P. H., and Li-Weber, M. (2006). HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP). Blood, 107, 3933-3939.

5. Muratori, C., D’Aloja, P., Superti, F., Tinari, A., Sol-Foulon, N., Sparacio, S., Bosch, V., Schwartz, O. and Federico, M. (2006). Generation and characterization of a stable cell population releasing fluorescent HIV-1-based Virus Like Particles in an inducible way. BMC Biotechnology, 6, 52.

6. Zeilfelder, U., Frank, O., Sparacio, S., Schön., Bosch, V., Seifarth, W., and Leib-Mösch, C. (2007). The potential of retroviral vectors to cotransfer human endogenous retroviruses (HERVs) fron human packaging cell lines. Gene, 390, 175-179.

7. Devitt, G., Emerson, V., Pisch, T., Keppler, O. T. and Bosch, V. (2007). Analysis of the exposure of induced HIV glycoprotein epitopes in a potential HIV pseudovirion vaccine. Vaccine, 25, 2161-2167.

8. Devitt, G., Emerson, V., Holtkotte, D., Pfeiffer, T., Pisch, T. and Bosch, V. (2007). Incorporation of chimeric HIV-SIV-Env and modified HIV-Env proteins into HIV pseudovirions. Virology, 361, 465-471.

9. Holtkotte, D., Pfeiffer, T., Bosch, V. Cell-free infectivity of HIV-1 produced in non-permissive cells is only moderately impacted by C-terminal Env truncation despite abrogation of viral spread. (2007). AIDS Res, and Human Retroviruses, 23, 729-740.

10. Devitt, G., Thomas, M., Klibinov, A. M., Pfeiffer, T. and Bosch, V. (2007). Optimized protocol for the large scale production of HIV pseudovirions by transient transfection of HEK293T cells with linear fully deacylated polyethylenimine. J. Virol. Methods, 146, 298-304.

11. Bosch, V., Pfeiffer, T., Devitt, G., Allespach, I., Ebensen, T., Emerson, V., Guzman, C. A. and Keppler, O. T. (2009), HIV pseudovirion vaccine exposing Env “fusion intermediates” – Response to immunisation in human CD4/CCR5-transgenic rats. Vaccine, 27, 2202-2212.

12. Emerson, V., Holtkotte, D., Pfeiffer, T, Wang, I.-H., Schnölzer, M., Kempf, T. and Bosch, V. (2010). Identification of the cellular prohibitin 1 and 2 heterodimer as interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoprotein. J. Virol., 84, 1355-1365.

13. Emerson, V., Haller, C., Pfeiffer, T., Fackler, O. T. and Bosch V. (2010). Role of the C-terminal domain of the HIV-1 glycoprotein in cell-to-cell viral transmission between T lymphocytes. Retrovirology 7:43